Trifluoroacetic acid → (S)-N-((S)-5-((2-Chloro-1-(2-cyanophenyl)-1H-indol-3-yl)methyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-2-(methylamino)propanamide
Reaction equation
C(O)(C(F)(F)F)=O.[Cl:8][C:9]1[N:10]([C:45]2[CH:50]=[CH:49][CH:48]=[CH:47][C:46]=2[C:51]#[N:52])[C:11]2[C:16]([C:17]=1[CH2:18][N:19]1[C:25](=[O:26])[C@@H:24]([NH:27][C:28](=[O:40])[C@@H:29]([N:31](C)[C:32](=O)OC(C)(C)C)[CH3:30])[CH2:23][O:22][C:21]3[CH:41]=[CH:42][CH:43]=[CH:44][C:20]1=3)=[CH:15][CH:14]=[CH:13][CH:12]=2>C(Cl)Cl>[Cl:8][C:9]1[N:10]([C:45]2[CH:50]=[CH:49][CH:48]=[CH:47][C:46]=2[C:51]#[N:52])[C:11]2[C:16]([C:17]=1[CH2:18][N:19]1[C:25](=[O:26])[C@@H:24]([NH:27][C:28](=[O:40])[C@@H:29]([NH:31][CH3:32])[CH3:30])[CH2:23][O:22][C:21]3[CH:41]=[CH:42][CH:43]=[CH:44][C:20]1=3)=[CH:15][CH:14]=[CH:13][CH:12]=2Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
TFA (5 mL) was added to a solution of tert-butyl (S)-1-((S)-5-((2-chloro-1-(2-cyanophenyl)-1H-indol-3-yl)methyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (130 mg, 207 μmol, Eq: 1.00) in DCM (5 mL). The mixture was stirred at RT for 16 h, then concentrated. Sat. NaHCO3 was added to the residue and the mixture was extracted with DCM. The combined organic extracts were concentrated and the residue purified by preparative TLC to give the title compound (50 mg, 43%) as a white solid. MS m/z 529 (MH+)
Workup
- concentrationconcentrated
- additionSat. NaHCO3 was added to the residue
- extractionthe mixture was extracted with DCM
- concentrationThe combined organic extracts were concentrated
- customthe residue purified by preparative TLC
Sources & evidence
- ORD record
- ord-ba0e533605f44d49936ca04c10a372d2
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09394263B2
Reaction notes
Loading…